TY - JOUR

T1 - Ökonomische Evaluation der Physiologischen Elektrolyttherapie bei Herzrhythmusstörungen

AU - Graf, J. M.

AU - Uber, A.

PY - 2001/12

Y1 - 2001/12

N2 - Aim: The costs of physiological electrolyte therapy in cardiac rhythm problems and its benefit will be evaluated. Method: In accordance with the German recommendations/guidelines on health economic evaluations, a record of costs will be carried out for the treatment of cardiac rhythm problems with potassium and magnesium, a synthetic antiarrhythmic drug, synthetic antiarrhythmic drug and potassium/magnesium. A decision tree will be developed from the data in order to estimate the resulting costs of cardiac rhythm problems. As a further ground for discussion, the quality of life will be measured using the SF-36 and EQ-5D. Results: The treatment costs of 172 study participants totalled 621,175 DM per year, equal to approximately 3,610 DM per patient. Patients who take the electrolyte preparation generate considerably more costs (up to 3,980 DM) than those patients who do not (795 DM), as the dose resulted additionally in the classical antiarrhythmica. The decision tree analysis shows, however, that the intake of the potassium-magnesium preparation leads to a less frequent claim for cost-inducing care programmes, to the extent that after three years of treatment up to 550 DM can be saved. Conclusion: The decision tree analysis shows that a long term administration of a medicine with a potassium/magnesium preparation can reduce costs, despite the electrolyte therapy being on average 515 DM more expensive.

AB - Aim: The costs of physiological electrolyte therapy in cardiac rhythm problems and its benefit will be evaluated. Method: In accordance with the German recommendations/guidelines on health economic evaluations, a record of costs will be carried out for the treatment of cardiac rhythm problems with potassium and magnesium, a synthetic antiarrhythmic drug, synthetic antiarrhythmic drug and potassium/magnesium. A decision tree will be developed from the data in order to estimate the resulting costs of cardiac rhythm problems. As a further ground for discussion, the quality of life will be measured using the SF-36 and EQ-5D. Results: The treatment costs of 172 study participants totalled 621,175 DM per year, equal to approximately 3,610 DM per patient. Patients who take the electrolyte preparation generate considerably more costs (up to 3,980 DM) than those patients who do not (795 DM), as the dose resulted additionally in the classical antiarrhythmica. The decision tree analysis shows, however, that the intake of the potassium-magnesium preparation leads to a less frequent claim for cost-inducing care programmes, to the extent that after three years of treatment up to 550 DM can be saved. Conclusion: The decision tree analysis shows that a long term administration of a medicine with a potassium/magnesium preparation can reduce costs, despite the electrolyte therapy being on average 515 DM more expensive.

KW - Cardiac rhythm problems

KW - Costs

KW - Electrolyte therapy

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=0035670814&partnerID=8YFLogxK

U2 - 10.1055/s-2001-19186

DO - 10.1055/s-2001-19186

M3 - Article

AN - SCOPUS:0035670814

VL - 6

SP - 153

EP - 160

JO - Gesundheitsokonomie und Qualitatsmanagement

JF - Gesundheitsokonomie und Qualitatsmanagement

SN - 1432-2625

IS - 6

ER -